Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
37,124,609
-
Shares change
-
+3,724,331
-
Total reported value, excl. options
-
$405,366,758
-
Value change
-
+$42,350,563
-
Put/Call ratio
-
12%
-
Number of buys
-
52
-
Number of sells
-
-35
-
Price
-
$10.95
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q2 2014
110 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q2 2014.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37,124,609 shares
of 56,047,431 outstanding shares and own 66% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (10,650,000 shares), Abingworth LLP (3,600,000 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,428,890 shares), Murphy Michael R (2,506,346 shares), ARDSLEY ADVISORY PARTNERS (1,765,000 shares), Ameriprise Financial Inc (1,732,581 shares), Consonance Capital Management LP (1,440,008 shares), Orchard Hill Capital Management LP (1,269,457 shares), BlackRock Fund Advisors (1,205,400 shares), and NORTHPOINTE CAPITAL LLC (1,019,819 shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.